| ALDR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALDR market cap history going back to 5/8/2014:
Also see: ALDR Shares Outstanding History and ALDR YTD Return |
ALDR Market Cap History — Alder Biopharmaceuticals Capitalization Over Time
As of 12/31/2018 Alder Biopharmaceuticals has a market cap of 521.65 million. Investors often follow the ALDR market cap history to compare the size of the company over time.
This page shows ALDR market capitalization trends over time, with 24 market cap datapoints presented, dating back to 5/8/2014.
| ALDR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
ALDR Historical Market Cap: +13.33% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| ALDR Stock Price Chart |
| About Alder Biopharmaceuticals Inc |
| Alder Biopharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to transform the treatment paradigm in migraine. Co. is focusing on eptinezumab (ALD403). Eptinezumab is a humanized immunoglobulin G1 monoclonal antibody for calcitonin gene-related peptide ligand, a small protein and a target to drive migraine initiation, maintenance and chronification. Co.'s product candidate pipeline also includes ALD1910, a neutralizing monoclonal antibody with reactivity to that targets pituitary adenylate cyclase-activating polypeptide-38. We show 24 historical shares outstanding datapoints in our ALDR shares outstanding history coverage, used to compute ALDR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALDR market cap history over the course of time is important for investors interested in comparing ALDR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALDR versus a peer is one thing; comparing ALDR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALDR can fluctuate over the course of history. With this page we aim to empower investors researching ALDR by allowing them to research the ALDR market cap history. |
| ALDR Current Stock Quote |
Quotes delayed 20 minutes  Free ALDR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ALDR Share Performance |
| Market Cap Peers |
| Alder Biopharmaceuticals (ALDR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ALDX Market Cap History ALEC Market Cap History ALGN Market Cap History ALGS Market Cap History ALHC Market Cap History ALIM Market Cap History ALKS Market Cap History ALLK Market Cap History ALLO Market Cap History ALLR Market Cap History More Healthcare companies » |
ALDR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
